DRD3_HUMAN - dbPTM
DRD3_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID DRD3_HUMAN
UniProt AC P35462
Protein Name D(3) dopamine receptor
Gene Name DRD3
Organism Homo sapiens (Human).
Sequence Length 400
Subcellular Localization Cell membrane
Multi-pass membrane protein . Both membrane-bound and scattered in the cytoplasm during basal conditions. Receptor stimulation results in the rapid internalization and sequestration of the receptors at the perinuclear area (5 and 15 m
Protein Description Dopamine receptor whose activity is mediated by G proteins which inhibit adenylyl cyclase. Promotes cell proliferation..
Protein Sequence MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
12N-linked_GlycosylationSQLSSHLNYTCGAEN
HHHHHHHCCCCCCCC
25.33UniProtKB CARBOHYD
19N-linked_GlycosylationNYTCGAENSTGASQA
CCCCCCCCCCCCCCC
44.32UniProtKB CARBOHYD
97N-linked_GlycosylationEVTGGVWNFSRICCD
EECCCCCCHHHHHHC
23.70UniProtKB CARBOHYD
142PhosphorylationPVHYQHGTGQSSCRR
ECCCCCCCCCCHHHH
29.89-
173N-linked_GlycosylationCPLLFGFNTTGDPTV
CHHHCCCCCCCCCCE
36.79UniProtKB CARBOHYD
225PhosphorylationRRRKRILTRQNSQCN
HHHHHHHHHCCCCCC
28.0417536008
229PhosphorylationRILTRQNSQCNSVRP
HHHHHCCCCCCCCCC
27.9817536008
233PhosphorylationRQNSQCNSVRPGFPQ
HCCCCCCCCCCCCCC
27.4217536008
257PhosphorylationLELKRYYSICQDTAL
HHHHHHHHHHHHHHC
14.1417536008
282 (in isoform 3)Phosphorylation-38.0627251275
282PhosphorylationELKREEKTRNSLSPT
CCCHHHHHHCCCCCC
38.0627251275
285PhosphorylationREEKTRNSLSPTIAP
HHHHHHCCCCCCCHH
27.2520068231
285 (in isoform 3)Phosphorylation-27.2522210691
287PhosphorylationEKTRNSLSPTIAPKL
HHHHCCCCCCCHHHH
21.5920068231
289PhosphorylationTRNSLSPTIAPKLSL
HHCCCCCCCHHHHCE
26.7920068231
295PhosphorylationPTIAPKLSLEVRKLS
CCCHHHHCEEEEECC
28.7220068231
302PhosphorylationSLEVRKLSNGRLSTS
CEEEEECCCCCCCCE
40.0320068231
309PhosphorylationSNGRLSTSLKLGPLQ
CCCCCCCEEECCCCC
21.82-
400S-palmitoylationAFLKILSC-------
HHHHHHCC-------
6.0727349735

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of DRD3_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of DRD3_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of DRD3_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CLIC6_HUMANCLIC6physical
14499480
MPDZ_HUMANMPDZphysical
14499480
GIPC1_HUMANGIPC1physical
14499480
RADI_HUMANRDXphysical
14499480
E41L1_HUMANEPB41L1physical
12181426
SL9A3_HUMANSLC9A3physical
24308971
UBP48_HUMANUSP48physical
24308971

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
190300Tremor, hereditary essential 1 (ETM1)
Kegg Drug
D00059 Levodopa (JP16/USP/INN); Dopar (TN)
D00454 Olanzapine (JAN/USAN/INN); Zyprexa (TN)
D00458 Quetiapine fumarate (JP16/USAN); Seroquel (TN)
D00559 Pramipexole hydrochloride hydrate (JAN); Pramipexole hydrochloride (USAN); Mirapex (TN)
D00560 Pimozide (JP16/USP/INN); Orap (TN)
D00633 Dopamine hydrochloride (JP16/USP); Actopamin (TN); Intropin (TN)
D01226 Sulpiride (JP16/USAN/INN); Dogmatyl (TN)
D01468 Nemonapride (JAN/INN); Emilace (TN)
D02676 Oxiperomide (USAN/INN)
D03891 Dopexamine (USAN/INN)
D05575 Pramipexole (USAN/INN)
D05682 Quinpirole hydrochloride (USAN)
D06623 Olanzapine pamoate (USAN); Olanzapine pamoate monohydrate
D07305 Piribedil (INN); Trivastal (TN)
D07312 Levosulpiride (INN); Levopraid (TN)
D07870 Dopamine (INN); Medopa (TN)
D08456 Quetiapine (INN); Norsic (TN)
D09366 Pardoprunox hydrochloride (USAN)
D09397 Pardoprunox (USAN/INN)
D09876 Cariprazine hydrochloride (JAN/USAN)
D09997 Cariprazine (USAN/INN)
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of DRD3_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP